| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/29/2005 | CN1631898A Mitochondria traffic protein molecule for human marrow stromal cell and sequence encoding same and use thereof |
| 06/29/2005 | CN1631897A Method for preparing thermophilic protein by heating and crushing genetic engineering bacterium |
| 06/29/2005 | CN1631896A Recombinant protein |
| 06/29/2005 | CN1208464C Maize H3C4 promoter associated with first rice actin intron, chimeric gene containing it and transformed plant |
| 06/29/2005 | CN1208463C Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 06/29/2005 | CN1208462C Human zinc finger protein family new gene ZNF325 |
| 06/29/2005 | CN1208461C New gene SNX21 of human SNX family |
| 06/29/2005 | CN1208458C Recombinant human platelet producing factor cDNA sequence and its use |
| 06/29/2005 | CN1208346C Blood substitute prepared by hematoglobin-human seralbumin conjugate and its preparation method |
| 06/29/2005 | CN1208345C Trimutant of recombinant human interleukin-2 and its preparation method |
| 06/29/2005 | CN1208344C Novel human cell endocytic regulatory protein, its coding sequence and use |
| 06/29/2005 | CN1208343C Trichosanthin mutant |
| 06/29/2005 | CN1208340C An infections clone for human parainfluenza virus type 3 |
| 06/29/2005 | CN1208065C Synergistic inhibition of viral replication long-chain hydrocarbons and nucleoside analogs |
| 06/28/2005 | US6912470 Nucleotide sequences coding enzymatic polypeptide for use in the production of anticarcinogenic and infection agents |
| 06/28/2005 | US6911577 Defensin polynucleotides and methods of use |
| 06/28/2005 | US6911538 Alternative (wild type) open reading frames are optimized for codon usage and expression of transcription factor and tumor supressor protein p53 proteins; useful in cancer therapy |
| 06/28/2005 | US6911537 Steroid and sensitive intracellular nuclear receptors as regulatory controls for gene transcription; metabolism regulation of physiologic homeostasis |
| 06/28/2005 | US6911535 Biomolecule/polymer conjugates |
| 06/28/2005 | US6911533 Polyclonal/monoclonal antibodies |
| 06/28/2005 | US6911532 Vertebrate apoptosis gene: compositions and methods |
| 06/28/2005 | US6911531 Antibodies directed towards a novel human EP prostaglandin receptor |
| 06/28/2005 | US6911530 Haemopoietin receptor and genetic sequences encoding same |
| 06/28/2005 | US6911529 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 06/28/2005 | US6911528 Comprises cholesterol modification |
| 06/28/2005 | US6911527 HIV related peptides |
| 06/28/2005 | US6911526 Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof |
| 06/28/2005 | US6911524 Antimicrobial peptides derived from mollusks |
| 06/28/2005 | US6911430 Compositions and methods for treating ileus |
| 06/28/2005 | US6911429 For therapy of arthritis, inflammatory dermatosis, inflammatory bowel disease, cancer, kidney fibrosis, inflammatory lung disease, obesity, lupus, cardiovascular disease and diabetes mellitus |
| 06/28/2005 | US6911428 Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 06/28/2005 | US6911427 No-modified hemoglobins and uses therefore |
| 06/28/2005 | US6911425 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 06/28/2005 | US6911334 Protease for activating clotting factor VII |
| 06/28/2005 | US6911332 Producing amino acids in microorganisms having enhanced or attenuated expression of these polypeptides and/or polynucleotides |
| 06/28/2005 | US6911329 Process for the fermentative preparation of D-pantothenic acid using coryneform bacteria |
| 06/28/2005 | US6911323 Human coagulation factor VII polypeptides |
| 06/28/2005 | US6911321 Non-human primate Fc receptors and methods of use |
| 06/28/2005 | US6911320 Pituitary tumor transforming gene (PTTG), formerly pituitary tumor specific gene (PTTG) |
| 06/28/2005 | US6911306 For diagnosis/therapy of abnormal methylation; apoptotic regulatory gene (TMS1); anticancer/tumor agents; gene expression inhibition |
| 06/28/2005 | US6911220 Inactivating mature recipient t cells and introducing into a primate recipient fetal or neonatal thymic tissue from a donor of a different species; restoring thymus dependent ability for progenitors to develop into mature t cells |
| 06/28/2005 | US6911208 Fungicides; diagnosis of pityrosporum infection; antiallergens |
| 06/28/2005 | US6911207 Cytotoxic T-cell epitopes of the papillomavirus L1-protein and use thereof in diagnostics and therapy |
| 06/28/2005 | US6911206 Fusion proteins comprising carriers that can induce a dual immune response |
| 06/28/2005 | US6911205 Stabilized soluble glycoprotein trimers |
| 06/28/2005 | US6911199 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/28/2005 | US6911178 Contacting the sample containing an antibody specific for isolated and purified antigenically-active blood group antigen protein or peptide to allow the formation of an immune complex; and detecting the immune complex |
| 06/28/2005 | CA2229744C Plastid inner envelope membrane targeting polypeptides: manufacture and use thereof |
| 06/28/2005 | CA2133831C Low toxicity interleukin-2 analogues for use in immunotherapy |
| 06/28/2005 | CA2113663C Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation |
| 06/28/2005 | CA2101924C Specific peptide sequences of hepatic stage p. falciparum bearing epitopes capable of stimulating t lymphocytes |
| 06/26/2005 | CA2486245A1 Albumin having enhanced antimicrobial activity |
| 06/23/2005 | WO2005057222A2 Use of t-cadherin as a target |
| 06/23/2005 | WO2005057166A2 Detection of conformationally altered proteins and prions |
| 06/23/2005 | WO2005056838A1 Association of tspyl polymorphisms with siddt syndrome |
| 06/23/2005 | WO2005056825A1 Screening for modulators of mekk2 and mekk3 |
| 06/23/2005 | WO2005056807A2 Bovine adeno-associated viral (baav) vector and uses thereof |
| 06/23/2005 | WO2005056801A1 Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them |
| 06/23/2005 | WO2005056800A1 A novel l-threonine importer from corynebacterium and a preparation method of a strain producing l-threonine |
| 06/23/2005 | WO2005056799A1 A cell with improved secretion mediated by mrga protein or homologue |
| 06/23/2005 | WO2005056791A1 Novel plexin polypeptide, dna encoding the same and use thereof |
| 06/23/2005 | WO2005056789A1 Cellular membrane composition and method of preparing the same |
| 06/23/2005 | WO2005056781A1 Use of proteins and peptides coded by the genome of a novel strain of sars-associated coronavirus |
| 06/23/2005 | WO2005056778A1 Method of regulating the differentiation of hematopoietic stem cells or proliferating the same |
| 06/23/2005 | WO2005056776A1 E.coli mutant containing mutant genes related with tryptophan biosynthesis and production method of tryptophan by using the same |
| 06/23/2005 | WO2005056773A1 Production of diphtheria toxin |
| 06/23/2005 | WO2005056764A2 Inhibitors of type 2 vascular endothelial growth factor receptors |
| 06/23/2005 | WO2005056752A2 Methods and compositions for delivering polynucleotides |
| 06/23/2005 | WO2005056597A1 IMMUNOGLOBULIN Fc RECEPTOR PROTEIN |
| 06/23/2005 | WO2005056596A1 Improved cytokine design |
| 06/23/2005 | WO2005056595A2 T cell receptor specific for wilms tumor antigen |
| 06/23/2005 | WO2005056594A1 Akt ACTIVITY SPECIFICALLY INHIBITING POLYPEPTIDE |
| 06/23/2005 | WO2005056593A2 Interactions between hsp90 and p50/cdc37 |
| 06/23/2005 | WO2005056592A1 Tumour suppressor protein |
| 06/23/2005 | WO2005056591A1 Glycine-rich proteins, their coding sequences and applications |
| 06/23/2005 | WO2005056590A1 Novel interaction between proteins, therapeutic agent for disuse atrophy utilizing the novel interaction, and method relating to disuse atrophy |
| 06/23/2005 | WO2005056589A1 Peptide having its self-assembling property induced at given salt concentration and self-assembled matter therefrom |
| 06/23/2005 | WO2005056588A1 A novel protein capable of inhibiting anthrax toxin activity |
| 06/23/2005 | WO2005056587A1 Inteins within fungal prp8 genes, uses thereof and assays |
| 06/23/2005 | WO2005056586A1 Lawsonia intracellularis 26 kd subunit vaccine |
| 06/23/2005 | WO2005056585A2 Sars coronavirus s proteins and uses thereof |
| 06/23/2005 | WO2005056584A2 Novel strain of sars-associated coronavirus and applications thereof |
| 06/23/2005 | WO2005056583A2 Plant virus |
| 06/23/2005 | WO2005056579A1 Interleukin 6 crystals having novel crystalline structure |
| 06/23/2005 | WO2005056577A2 Peptide inhibitors of hiv |
| 06/23/2005 | WO2005056572A2 Clustered multi-antigenic carbohydrate constructs, methods for their preparation and uses thereof |
| 06/23/2005 | WO2005056569A2 Beta integrin gene and protein |
| 06/23/2005 | WO2005056057A1 Minimal lentiviral vector system |
| 06/23/2005 | WO2005056053A1 Use of goat serum for veterinary treatment |
| 06/23/2005 | WO2005056051A2 Hepatitis b vaccines and compositions |
| 06/23/2005 | WO2005056046A2 Methods for treating inflammation using thyroid stimulating hormone |
| 06/23/2005 | WO2005056043A2 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 06/23/2005 | WO2005056039A1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 06/23/2005 | WO2005056036A2 Regulation of food preference using glp-1 agonists |
| 06/23/2005 | WO2005055957A2 Influenza immunogen and vaccine |
| 06/23/2005 | WO2005055942A2 Modulation of brain pathways and function |
| 06/23/2005 | WO2005055930A2 Recombinant factor viii having increased specific activity |
| 06/23/2005 | WO2005055707A1 Mouse with dysfunctional enamelin gene |
| 06/23/2005 | WO2005055706A1 DISEASE MODEL ANIMAL EXPRESSING MEGSIN/RAGE/iNOS AND METHOD OF EVALUATING COMPOUND WITH THE USE OF THE ANIMAL |
| 06/23/2005 | WO2005055703A2 Method of modifying plant phenotypes with nonsymbiotic hemoglobin |